Cognivia Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $19M

  • Investors
  • 8

Cognivia General Information

Description

Developer of medical analytical tools designed to optimize and accelerate the clinical development of new medicines. The company's tool aims to develop predictive techniques that improve and accelerate the clinical evaluation of drugs and other therapeutics and mitigate the impact of the response in clinical trials, enabling clients to identify and manage key sources of variability within clinical trial data.

Contact Information

Website
www.cognivia.com
Formerly Known As
Tools4Patient
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11, rue Granbonpré
  • 1435 Mont-Saint-Guibert
  • Belgium
+32 071
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Vertical(s)
Big Data, SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 11, rue Granbonpré
  • 1435 Mont-Saint-Guibert
  • Belgium
+32 071

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cognivia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 18-Apr-2024 $19M Completed Generating Revenue
7. Later Stage VC 28-Dec-2021 Completed Generating Revenue
6. Later Stage VC (Series B) 16-May-2019 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Early Stage VC 16-Jun-2016 Completed Generating Revenue
3. Early Stage VC 19-Feb-2016 Completed Generating Revenue
2. Early Stage VC 01-May-2015 $813K $1.76M Completed Generating Revenue
1. Early Stage VC 03-Nov-2014 $949K $949K Completed Generating Revenue
To view Cognivia’s complete valuation and funding history, request access »

Cognivia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class C
Class B
Class C
Class B
Class A
Class A
Class A
Class B
Class B 5,000 $118.68 $118.68 1x $118.68 0.93%
Class B 2,155 $110.11 $110.11 1x $110.11 0.4%
To view Cognivia’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cognivia Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Cognivia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240371478-A1 Method for providing dynamically customized messages in a healthcare facility Pending 04-May-2023
EP-2987451-A1 Method and tools for predicting a pain response in a subject Inactive 18-Aug-2014
US-20160048659-A1 Method and tools for predicting a pain response in a subject suffering from cancer-induced bone pain Inactive 18-Aug-2014
US-20150317447-A1 Method for prediction of a placebo response in a individual suffering from or at risk to a pain disorder Inactive 05-May-2014
AU-2015257780-A1 Method for prediction of a placebo response in an individual Inactive 05-May-2014 G16H50/30
To view Cognivia’s complete patent history, request access »

Cognivia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cognivia Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Société Fédérale de Participations et d'Investissement Holding Company Minority
Vesalius Biocapital Partners Venture Capital Minority
Wallonie Entreprendre Growth/Expansion Minority
Carbon ( Belgium ) Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Cognivia FAQs

  • When was Cognivia founded?

    Cognivia was founded in 2013.

  • Where is Cognivia headquartered?

    Cognivia is headquartered in Mont-Saint-Guibert, Belgium.

  • What is the size of Cognivia?

    Cognivia has 26 total employees.

  • What industry is Cognivia in?

    Cognivia’s primary industry is Discovery Tools (Healthcare).

  • Is Cognivia a private or public company?

    Cognivia is a Private company.

  • What is the current valuation of Cognivia?

    The current valuation of Cognivia is .

  • What is Cognivia’s current revenue?

    The current revenue for Cognivia is .

  • How much funding has Cognivia raised over time?

    Cognivia has raised $29.8M.

  • Who are Cognivia’s investors?

    Société Fédérale de Participations et d'Investissement, Vesalius Biocapital Partners, Wallonie Entreprendre, Carbon ( Belgium ), and are 5 of 8 investors who have invested in Cognivia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process